A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus

by | Aug 31, 2026 | Clinical Trials | 0 comments

​ Conditions: Diabete Mellitus; Diabete Type 2

Interventions: Biological: RGB-5088

Sponsors: Hangzhou Reprogenix Bioscience, Inc

Not yet recruiting Conditions: Diabete Mellitus; Diabete Type 2
Interventions: Biological: RGB-5088
Sponsors: Hangzhou Reprogenix Bioscience, Inc
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *